Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Understand the usual disbursement timing after refinance approval and actions that can speed or delay access to funds.
21,084 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
KB Home accelerated its land replenishment in 2024, then signaled a slower pace in 2025. The shift could influence wh...
Apple unveils upgraded Siri marks a turning point for voice AI on iPhone and beyond. This article explores what’s new...
Nio delivered a staggering 129% jump in EV sales, yet its stock slid in May. This analysis breaks down the drivers be...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Bitcoin struggles to hold support around $61,000 as geopolitical flashpoints and CPI data loom. SpaceX's upcoming IPO...
A writer and friend test a cold plunge before a work-from-home day, reporting a sharper, calmer morning. The piece ex...
Meta unveils a bold workforce program that funds a 5-week training path and guarantees employment for data-center tec...
As a record World Cup unfolds across U.S. cities this summer, economists expect international arrivals to surge, lift...
When flashy IPOs grab headlines, smart investors look for steady income and resilience. Here are three boring dividen...
XRP is testing a pivotal support area after a steep two-week selloff. The bounce remains fragile, keeping downside ri...
The White House motioned Jay Clayton for a permanent DNI post while signaling that acting DNI Bill Pulte will step do...